Vericel was founded in 2003. Initially, they focused on the development and delivery of advanced autologous cell therapies, primarily for the treatment of damaged joint cartilage. Since then, they have expanded their focus and product portfolio to include tissue repair in multiple indications including skin and burn care, muscle and tendon repair, and other medical conditions. Since their start, Vericel has helped pioneer the way for scientifically-validated and cost-effective cell therapy treatments.
